Osteopore (ASX:OSX) signed a deal with Swiss Stock Exchange-listed holding firm DiethelmKellerSiberHegner (DKSH) to market and sell Osteopore's off-the-shelf orthopedic products in Singapore, according to a Wednesday filing with the Australian bourse.
As per the multi-year deal, DKSH will promote the company's bone loss treatment products in Singapore, the filing said.
The deal comes after receiving market approvals in March.
Osteopore's shares were up almost 3% in recent Wednesday trade.
Price (AUD): $0.04, Change: $+0.001, Percent Change: +2.56%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。